W.R. Huff Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.52M Sell
25,995
-5
-0% -$273 1.31% 27
2016
Q3
$1.4M Buy
26,000
+16,115
+163% +$1.04M 1.11% 26
2016
Q2
$727K Hold
9,885
0.61% 35
2016
Q1
$631K Hold
9,885
0.58% 36
2015
Q4
$680K Hold
9,885
0.61% 36
2015
Q3
$585K Hold
9,885
0.54% 33
2015
Q2
$658K Hold
9,885
0.53% 36
2015
Q1
$638K Hold
9,885
0.56% 37
2014
Q4
$584K Buy
+9,885
New +$557K 0.45% 34

Other funds holding BMY

W.R. Huff Asset Management's BMY Position: Q4 2016 in Review

W.R. Huff Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.02% in Q4 2016, selling an estimated $273 and leaving 25,995 shares worth $1.52M. The position accounts for 1.31% of the portfolio, ranked #27.

W.R. Huff Asset Management first reported a position in BMY in Q4 2014 and has held it in 9 quarters since. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

  • W.R. Huff Asset Management held 25,995 shares of Bristol-Myers Squibb worth $1.52M as of Q4 2016.
  • W.R. Huff Asset Management sold 5 Bristol-Myers Squibb shares in Q4 2016, an estimated $273.
  • Bristol-Myers Squibb made up 1.31% of W.R. Huff Asset Management's portfolio in Q4 2016, its #27 holding.
  • W.R. Huff Asset Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 9 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on W.R. Huff Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.